Ipsen – Monthly information relative to the total number of voting rights and shares composing the share capital
Monthly information relative to the total number of voting rights
and shares composing the share capital
(in accordance with Article L.233-8 II of the French Commercial Code and
Article 223-16 of the General Regulation of the Autorité des Marchés Financiers)
Market: Euronext Paris
ISIN Code: FR 0010259150
LEI: 549300M6SGDPB4Z94P11
| Date | Total number of shares composing the share capital | Total number of voting rights (1) |
| 31 October 2023 | 83,814,526 | Gross total* of voting rights: 132,088,161 |
| Net total** of voting rights: 130,981,182 |
(1) Existence of a statutory clause imposing an obligation to declare threshold crossing complementary to the one relative to the legal thresholds (Article 10).
* Gross total = total number of voting rights attached to the total number of shares, including the number of shares which benefit of double voting rights and the number of treasury shares. The « Gross total » is used as a basis for the calculation of threshold crossings.
** Net total = total number of voting rights attached to the total number of shares – shares without voting rights.
Attachment
Excellence in action: Ipsen is first pharma company to receive two Gold Shingo Prizes
Ipsen announces U.S. FDA Priority Review for palovarotene New Drug Application in patients with fibrodysplasia ossificans progressiva following resubmission
Ipsen announces the launch of an Employee Shareholding Plan